Immunogen | IMGN - Ebitda



Ebitda تغییر دادن تاریخ
AbbVie USD 3.52B 828M 2025-09
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Amgen USD 5.14B 775M 2025-12
Astellas Pharma JPY 183.68B 31.98B 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Exelixis USD 248.93M 28.02M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Intrexon USD -24.7M 2.92M 2024-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD 21.95M 55.39M 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Novartis USD 5.84B 235M 2025-09
Pfizer USD 6.08B 351M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 5.66B 3.77B 2025-09